BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

729 related articles for article (PubMed ID: 25359619)

  • 1. Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer.
    Johnson RW; Merkel AR; Page JM; Ruppender NS; Guelcher SA; Sterling JA
    Clin Exp Metastasis; 2014 Dec; 31(8):945-59. PubMed ID: 25359619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-beta promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signaling.
    Johnson RW; Nguyen MP; Padalecki SS; Grubbs BG; Merkel AR; Oyajobi BO; Matrisian LM; Mundy GR; Sterling JA
    Cancer Res; 2011 Feb; 71(3):822-31. PubMed ID: 21189326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hedgehog signaling molecule Gli2 induces parathyroid hormone-related peptide expression and osteolysis in metastatic human breast cancer cells.
    Sterling JA; Oyajobi BO; Grubbs B; Padalecki SS; Munoz SA; Gupta A; Story B; Zhao M; Mundy GR
    Cancer Res; 2006 Aug; 66(15):7548-53. PubMed ID: 16885353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells.
    Pratap J; Wixted JJ; Gaur T; Zaidi SK; Dobson J; Gokul KD; Hussain S; van Wijnen AJ; Stein JL; Stein GS; Lian JB
    Cancer Res; 2008 Oct; 68(19):7795-802. PubMed ID: 18829534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix rigidity regulates the transition of tumor cells to a bone-destructive phenotype through integrin β3 and TGF-β receptor type II.
    Page JM; Merkel AR; Ruppender NS; Guo R; Dadwal UC; Cannonier S; Basu S; Guelcher SA; Sterling JA
    Biomaterials; 2015 Sep; 64():33-44. PubMed ID: 26115412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discoidin domain receptor 2 facilitates prostate cancer bone metastasis via regulating parathyroid hormone-related protein.
    Yan Z; Jin S; Wei Z; Huilian H; Zhanhai Y; Yue T; Juan L; Jing L; Libo Y; Xu L
    Biochim Biophys Acta; 2014 Sep; 1842(9):1350-63. PubMed ID: 24787381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA BCAR4 promotes osteosarcoma progression through activating GLI2-dependent gene transcription.
    Chen F; Mo J; Zhang L
    Tumour Biol; 2016 Oct; 37(10):13403-13412. PubMed ID: 27460090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hedgehog and TGFβ signaling converge on Gli2 to control bony invasion and bone destruction in oral squamous cell carcinoma.
    Cannonier SA; Gonzales CB; Ely K; Guelcher SA; Sterling JA
    Oncotarget; 2016 Nov; 7(46):76062-76075. PubMed ID: 27738315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt-mediated regulation of chondrocyte maturation: modulation by TGF-beta.
    Dong Y; Drissi H; Chen M; Chen D; Zuscik MJ; Schwarz EM; O'Keefe RJ
    J Cell Biochem; 2005 Aug; 95(5):1057-68. PubMed ID: 15962307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-Thioguanine inhibition of parathyroid hormone-related protein expression is mediated by GLI2.
    Johnson RW; Merkel AR; Danilin S; Nguyen MP; Mundy GR; Sterling JA
    Anticancer Res; 2011 Sep; 31(9):2705-12. PubMed ID: 21868511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The murine gastrin promoter is synergistically activated by transforming growth factor-beta/Smad and Wnt signaling pathways.
    Lei S; Dubeykovskiy A; Chakladar A; Wojtukiewicz L; Wang TC
    J Biol Chem; 2004 Oct; 279(41):42492-502. PubMed ID: 15292219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning of the human GLI2 Promoter: transcriptional activation by transforming growth factor-beta via SMAD3/beta-catenin cooperation.
    Dennler S; André J; Verrecchia F; Mauviel A
    J Biol Chem; 2009 Nov; 284(46):31523-31. PubMed ID: 19797115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribosomal protein S3 regulates GLI2-mediated osteosarcoma invasion.
    Nagao-Kitamoto H; Setoguchi T; Kitamoto S; Nakamura S; Tsuru A; Nagata M; Nagano S; Ishidou Y; Yokouchi M; Kitajima S; Yoshioka T; Maeda S; Yonezawa S; Komiya S
    Cancer Lett; 2015 Jan; 356(2 Pt B):855-61. PubMed ID: 25449781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor beta regulates parathyroid hormone-related protein expression in MDA-MB-231 breast cancer cells through a novel Smad/Ets synergism.
    Lindemann RK; Ballschmieter P; Nordheim A; Dittmer J
    J Biol Chem; 2001 Dec; 276(49):46661-70. PubMed ID: 11590145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta in osteolytic breast cancer bone metastases.
    Guise TA; Chirgwin JM
    Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S32-8. PubMed ID: 14600590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt/β-catenin signaling mediates the antitumor activity of magnolol in colorectal cancer cells.
    Kang YJ; Park HJ; Chung HJ; Min HY; Park EJ; Lee MA; Shin Y; Lee SK
    Mol Pharmacol; 2012 Aug; 82(2):168-77. PubMed ID: 22550094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parathyroid Hormone-Related Protein Interacts With the Transforming Growth Factor-β/Bone Morphogenetic Protein-2/Gremlin Signaling Pathway to Regulate Proinflammatory and Profibrotic Mediators in Pancreatic Acinar and Stellate Cells.
    Bhatia V; Cao Y; Ko TC; Falzon M
    Pancreas; 2016; 45(5):659-70. PubMed ID: 26495794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GLI2-mediated melanoma invasion and metastasis.
    Alexaki VI; Javelaud D; Van Kempen LC; Mohammad KS; Dennler S; Luciani F; Hoek KS; Juàrez P; Goydos JS; Fournier PJ; Sibon C; Bertolotto C; Verrecchia F; Saule S; Delmas V; Ballotti R; Larue L; Saiag P; Guise TA; Mauviel A
    J Natl Cancer Inst; 2010 Aug; 102(15):1148-59. PubMed ID: 20660365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 14-3-3ζ turns TGF-β's function from tumor suppressor to metastasis promoter in breast cancer by contextual changes of Smad partners from p53 to Gli2.
    Xu J; Acharya S; Sahin O; Zhang Q; Saito Y; Yao J; Wang H; Li P; Zhang L; Lowery FJ; Kuo WL; Xiao Y; Ensor J; Sahin AA; Zhang XH; Hung MC; Zhang JD; Yu D
    Cancer Cell; 2015 Feb; 27(2):177-92. PubMed ID: 25670079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development.
    Yin JJ; Selander K; Chirgwin JM; Dallas M; Grubbs BG; Wieser R; Massagué J; Mundy GR; Guise TA
    J Clin Invest; 1999 Jan; 103(2):197-206. PubMed ID: 9916131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.